Revascularization of damaged tissue is a necessary part of wound healing. With unregulated or insufficient vessel growth, healing is delayed or pathological. Angiogenesis is regulated by expression of a variety of vascular growth factors and modulators, the most widely expressed and critical of which is vascular endothelial growth factor (VEGF). This protein is secreted by tissues in response to ischemic and inflammatory stimuli and results in endothelial migration, proliferation, and increased vascular permeability. The regulation of VEGF expression during wound healing is of considerable importance since angiogenesis appears to be disturbed in abnormally healing wounds. This paper describes the current state of knowledge of VEGF expression in wounds, regulation of expression, control of isoform specificity, and the effects of VEGF expression on blood vessels as they grow in wound healing, as understood from many different pathological paradigms.
Get full access to this article
View all access options for this article.
References
1.
1. Drinkwater SL, Smith A, Sawyer BM, Burnand KG. Effect of venous ulcer exudates on angiogenesis in vitro . Br J Surg2002;89(6): 709-713 .
2.
2. Taub PJ, Silver L, Weinberg H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis . Plast Reconstr Surg2000;105(3): 1034-1042 .
3.
3. Power C, Wang JH, Sookhai S, Street JT, Redmond HP. Bacterial wall products induce down-regulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: implications for surgical wound healing . J Surg Res2001;101(2): 138-145 .
4.
4. Kumar C, Cotran RS, Robbins SL. Basic pathology. 6th ed. Philadelphia (PA): WB Saunders ; 1997.
5.
5. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing . J Biol Chem2002;277(36): 33284-33290 .
6.
6. Chintalgattu V, Nair DM, Katwa LC. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR . J Mol Cell Cardiol2003;35(3): 277-286 .
7.
7. Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, Brenchley PE. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid . Clin Exp Immunol1999;117(1): 171-176 .
8.
8. Griga T, Werner S, Koller M, Tromm A, May B. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labelling of peripheral CD14+ monocytes . Dig Dis Sci1999;44(6): 1196-1201 .
9.
9. Satake S, Kuzuya M, Miura H, et al. Up-regulation of vascular endothelial growth factor in response to glucose deprivation . Biol Cell1998;90(2): 161-168 .
10.
10. Artuc M, Hermes B, Steckelings UM, Grutzkau A, Henz BM. Mast cells and their mediators in cutaneous wound healing—active participants or innocent bystanders? Exp Dermatol1999;8(1): 1-16 .
11.
11. Madden JW, Peacock EE, Jr. Studies on the biology of collagen during wound healing. 3. Dynamic metabolism of scar collagen and remodeling of dermal wounds . Ann Surg1971;174(3): 511-520 .
13. Takamiya M, Saigusa K, Aoki Y. Immunohistochemical study of basic fibroblast growth factor and vascular endothelial growth factor expression for age determination of cutaneous wounds . Am J Forensic Med Pathol2002;23(3): 264-267 .
14.
14. Ozawa K, Kondo T, Hori O, et al. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport . J Clin Invest2001;108(1): 41-50 .
15.
15. Bloch W, Huggel K, Sasaki T, et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing . Faseb J2000;14(15): 2373-2376 .
16.
16. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing . J Investig Dermatol Symp Proc2000;5(1): 40-46 .
17.
17. Brown NJ, Smyth EA, Cross SS, Reed MW. Angiogenesis induction and regression in human surgical wounds . Wound Repair Regen2002;10(4): 245-251 .
18.
18. Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair . Lab Invest2001;81(3): 361-373 .
19.
19. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications . Semin Oncol2002;29(6 Suppl 16): 10-14 .
20.
20. Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability . Microcirculation1999;6(2): 83-96 .
21.
21. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells . Biochem Biophys Res Commun1989;161(2): 851-858 .
22.
22. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induced interstitial collagenase expression in human endothelial cells . J Cell Physiol1992;153(3): 557-562 .
23.
23. Koolwijk P, Van Erck M, De Vree W, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix: role of urokinase activity . J Cell Biol1996;132(6): 1177-1188 .
25. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid . Science1983;219(4587): 983-985 .
26.
26. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis . J Clin Invest1989;84(5): 1470-1478 .
27.
27. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer . Hum Pathol1995;26(1): 86-91 .
28.
28. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas . Am J Pathol1993;143(5): 1255-1262 .
29.
29. Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney . Kidney Int1992;42(6): 1457-1461 .
30.
30. Brown LF, Harrist TJ, Yeo KT, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme . J Invest Dermatol1995;104(5): 744-749 .
31.
31. Brown LF, Yeo KT, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing . J Exp Med1992;176(5): 1375-1379 .
32.
32. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis . Am J Physiol Cell Physiol2001;280(6): C1358-C1366 .
33.
33. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA . Mol Endocrinal1991;5(12): 1806-1814 .
34.
34. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors . Faseb J1999;13(1): 9-22 .
35.
35. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability . FEBS Lett1995;370(3): 203-208 .
36.
36. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia . J Biol Chem1995;270(22): 13333-13340 .
37.
37. Huez I, Creancier L, Audigier S, Gensac MC, Prats AC, Prats H. Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA . Mol Cell Biol1998;18(11): 6178-6190 .
38.
38. Miller DL, Dibbens JA, Damert A, Risau W, Vadas MA, Goodall GJ. The vascular endothelial growth factor mRNA contains an internal ribosome entry site . FEBS Lett1998;434(3): 417-420 .
39.
39. Akiri G, Nahari D, Finkelstein Y, Le SY, Elroy-Stein O, Levi BZ. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription . Oncogene1998;17(2): 227-236 .
40.
40. Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia . Mol Cell Biol1998;18(6): 3112-3119 .
41.
41. Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes . Mol Cell Biol1995;15(10): 5363-5368 .
42.
42. Namiki A, Brogi E, Kearney M, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells . J Biol Chem1995;270(52): 31189-31195 .
43.
43. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo . Lab Invest1994;71(3): 374-379 .
44.
44. Berra E, Pages G, Pouyssegur J. MAP kinases and hypoxia in the control of VEGF expression . Cancer Metastasis Rev2000;19(1-2): 139-145 .
46. Scheid A, Wenger RH, Christina H, et al. Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair . Pediatr Surg Int2000;16(4): 232-236 .
47.
47. Detmar M, Brown LF, Berse B, et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin . J Investig Dermatol1997;108(3): 263-268 .
48.
48. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis . Semin Cell Dev Biol2002;13(1): 29-37 .
49.
49. McNeill LA, Hewitson KS, Gleadle JM, et al. The use of dioxygen by HIF prolyl hydroxylase (PHD1) . Bioorg Med Chem Lett2002;12(12): 1547-1550 .
50.
50. Yu F, White SB, Zhao Q, Lee FS. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation . Proc Natl Acad Sci USA2001;98(17): 9630-9635 .
51.
51. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing . Science2001;292(5516): 464-468 .
52.
52. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation . Science2001;292(5516): 468-472 .
53.
53. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences . J Biol Chem1995;270(49): 29083-29089 .
54.
54. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes . Blood1999;94(12): 4177-4185 .
55.
55. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia . J Biol Chem1997;272(38): 23659-23667 .
56.
56. Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells . J Biol Chem2000;275(19): 14139-14146 .
57.
57. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1 . Am J Physiol1998;274(2 Pt 1): L212-L219 .
58.
58. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2 . Cancer Res1999;59(16): 3915-3918 .
59.
59. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia . J Biol Chem1996;271(5): 2746-2753 .
60.
60. Levy AP, Levy NS, Goldberg MA. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein . J Biol Chem1996;271(41): 25492-25497 .
61.
61. Tang K, Breen EC, Wagner PD. Hu protein R-mediated posttranscriptional regulation of VEGF expression in rat gastrocnemius muscle . Am J Physiol Heart Circ Physiol2002;283(4): H1497-H1504 .
62.
62. Goldberg-Cohen I, Furneaux H, Levy AP. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR . J Biol Chem2002;277(16): 13635-13640 .
63.
63. Scandurro AB, Beckman BS. Common proteins bind mRNAs encoding erythropoietin, tyrosine hydroxylase, and vascular endothelial growth factor . Biochem Biophys Res Commun1998;246(2): 436-440 .
64.
64. Levy NS, Goldberg MA, Levy AP. Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites . Biochim Biophys Acta1997;1352(2): 167-173 .
65.
65. Iida K, Kawakami Y, Sone H, et al. Vascular endothelial growth factor gene expression in a retinal pigmented cell is up-regulated by glucose deprivation through 3' UTR . Life Sci2002;71(14): 1607-1614 .
66.
66. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation . Int Arch Allergy Immunol1995;107(1-3): 233-235 .
67.
67. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis . FEBS Lett1995;372(1): 83-87 .
68.
68. Li J, Perrella MA, Tsai JC, et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells . J Biol Chem1995;270(1): 308-312 .
69.
69. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor . J Biol Chem1996;271(2): 736-741 .
70.
70. Corne J, Chupp G, Lee CG, et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury . J Clin Invest2000;106(6): 783-791 .
71.
71. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response . Annu Rev Immunol2002;20: 55-72 .
72.
72. Tanaka T, Kanai H, Sekiguchi K, et al. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes . J Mol Cell Cardiol2000;32(11): 1955-1967 .
73.
73. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing . Arch Surg1999;134(2): 200-205 .
74.
74. Irwela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors . Thromb Haemost1997;78(1): 672-677 .
75.
75. Kishimoto J, Ehama R, Ge Y, et al. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin . Am J Pathol2000;157(1): 103-110 .
76.
76. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides . J Cell Biochem1991;47(3): 211-218 .
77.
77. Bates DO, Cui T-G, Doughty JM, et al. VEGF165b: an inhibitory splice variant of vascular endothelial growth factor—is down-regulated in renal cell carcinoma . Cancer Res2002;62(July 15): 1-9 .
78.
78. Potgens AJ, Lubsen NH, van Altena MC, et al. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity: evidence from Cys to Ser mutations . J Biol Chem1994;269(52): 32879-32885 .
79.
79. Keck RG, Berleau L, Harris R, Keyt BA. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF . Arch Biochem Biophys1997;344(1): 103-113 .
80.
80. Cui T-G, Harper SJ, Bates DO. VEGF165b competitively inhibits VEGF165 binding to HUVECS and VEGF-R2 . J Vasc Res2003: in press.
81.
81. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors . Vascul Pharmacol2002;39(4-5): 225-237 .
82.
82. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries . Am J Physiol Heart Circ Physiol1993;265(2 Pt 2): H586-H592 .
83.
83. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium . Proc Natl Acad Sci USA1993;90(16): 7533-7537 .
84.
84. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor . Endocr Rev1997;18(1): 4-25 .
85.
85. Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA. The Shc-related adaptor protein, Sck, forms a complex with the vascular endothelial growth factor receptor KDR in transfected cells . Biochem J2000;347(Pt 2): 501-509 .
86.
86. Brogley MA, Cruz M, Cheung HS. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway . J Cell Physiol1999;180(2): 215-224 .
87.
87. Westermarck J, Holmstrom T, Ahonen M, Eriksson JE, Kahari VM. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38 . Matrix Biol1998;17(8-9): 547-557 .
88.
88. Lamoreaux WJ, Fitzgerald M, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro . Microvasc Res1998;55(1): 29-42 .
89.
89. Foster RR, Hole R, Anderson K, et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes . Am J Physiol Renal Physiol2003;284(6): F1263-F1273 .
90.
90. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules . Am J Physiol Heart and Circulatory Physiol1996;271(6): H2735-H2739 .
91.
91. Bates DO. The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric microvessels . J Physiol (Lond)1998;513(Pt 1): 225-233 .
92.
92. Cohen AW, Carbajal JM, Schaeffer RC, Jr. VEGF stimulates tyro-sine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction . Am J Physiol1999;277(5 Pt 2): H2038-H2049 .
93.
93. Bates DO, Heald RI, Curry FE, Williams B. Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways . J Physiol2001;533(Pt 1): 263-272 .
94.
94. Pocock TM, Bates DO. In vivo mechanisms of vascular endothelial growth factor-mediated increased hydraulic conductivity of Rana capillaries . J Physiol2001;534(Pt. 2): 479-488 .
95.
95. Whittles CE, Pocock TM, Wedge SR, et al. ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity . Microcirculation2002;9(6): 513-522 .
96.
96. Hillman NJ, Whittles CE, Pocock TM, Williams B, Bates DO. Differential effects on microvascular hydraulic conductivity (Lp) of vascular endothelial growth factor C (VEGF-C) and placental growth factor-1 (PlGF-1) . J Vasc Res2001;38: 176-185 .
97.
97. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor . J Biol Chem1994;269(43): 26988-26995 .
98.
98. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol . Nature1999;397(6716): 259-263 .
99.
99. Pocock TM, Williams B, Curry FE, Bates DO. VEGF and ATP act by different mechanisms to increase microvascular permeability and endothelial [Ca(2+)](i) . Am J Physiol Heart Circ Physiol2000;279(4): H1625-H1634 .
100.
100. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Vesiculovacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin . J Exp Med1996;183(5): 1981-1986 .
101.
101. Feng X, Clark RA, Galanakis D, Tonnesen MG. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3 mRNA by fibrin1 . J Invest Dermatol1999;113(6): 913-919 .
102.
102. Michel CC, Neal CR. Openings through endothelial cells associated with increased microvascular permeability . Microcirculation1999;6(1): 45-54 .
103.
103. Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. Regulation of microvascular permeability by vascular endothelial growth factors . J Anat2002;200(6): 581-597 .
104.
104. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators . Microcirculation1999;6(1): 23-44 .
105.
105. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix . Microsc Res Tech2003;60(1): 107-114 .
106.
106. D'Angelo G, Struman I, Martial J, Weiner RI. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N- terminal fragment of prolactin . Proc Natl Acad Sci USA1995;92(14): 6374-6378 .
107.
107. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells . J Biol Chem1998;273(36): 23504-23508 .
108.
108. Bains W. Vasoprotective VEGF as a candidate for prevention of recurrence of fibrotic diseases such as Dupuytren's contracture . Med Hypotheses2003;60(6): 793-796 .
109.
109. Guarini S. New gene therapy for the treatment of burn wounds . Crit Care Med2003;31(4): 1280-1281 .
110.
110. Galeano M, Deodato B, Altavilla D, et al. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury . Crit Care Med2003;31(4): 1017-1025 .
111.
111. Galeano M, Deodato B, Altavilla D, et al. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse . Diabetologia2003;46(4): 546-555 .
112.
112. Seify H, Bulky U, Jones G. Effect of vascular endothelial growth factor-induced angiogenesis on TRAM flap harvesting after abdominoplasty . Plast Reconstr Surg2003;111(3): 1212-1216 .
113.
113. Dodge-Khatami A, Niessen HW, Baidoshvili A, et al. Topical vascular endothelial growth factor in rabbit tracheal surgery: comparative effect on healing using various reconstruction materials and intraluminal stents . Eur J Cardiothorac Surg2003;23(1): 6-14 .
114.
114. Deodato B, Arsic N, Zentilin L, et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing . Gene Ther2002;9(12): 777-785 .
115.
115. Tsou R, Fathke C, Wilson L, Wallace K, Gibran N, Isik F. Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibits wound angiogenesis . Wound Repair Regen2002;10(4): 222-229 .
116.
116. London NJ, Donnelly R. ABC of arterial and venous disease: ulcerated lower limb . BMJ2000;320(7249): 1589-1591 .
117.
117. Ghauri AS, Nyamekye I, Grabs AJ, Farndon JR, Poskitt KR. The diagnosis and management of mixed arterial/venous leg ulcers in community-based clinics . Eur J Vasc Endovasc Surg1998;16(4): 350-355 .
118.
118. Lamah M, Mortimer PS, Dormandy JA. In vivo microscopic study of microcirculatory perfusion of the skin of the foot in peripheral vascular disease . Eur J Vasc Endovasc Surg1999;18(1): 48-51 .
119.
119. Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes . Clin Sci (Lond)2002;102(2): 187-194 .
120.
120. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events: the Framingham Study . Diabetes1989;38(4): 504-509 .
121.
121. Stegmann TJ, Hoppert T, Schneider A, et al. Induction of myocardial neoangiogenesis by human growth factors: a new therapeutic approach in coronary heart disease . Herz2000;25(6): 589-599 .
122.
122. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia . Gene Ther2003;10(4): 285-291 .
123.
123. Nikol S, Huehns TY. Pre-clinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy . J Invasive Cardiol2001;13(4): 333-338 .
124.
124. Laham R. Angiogenesis (clinical trials) . Can J Cardiol2001;17(Suppl A): 29A-32A .
125.
125. Kipshidze N, Chekanov V, Chawla P, et al. Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform . Tex Heart Inst J2000;27(2): 196-200 .
